Programme

 

THURSDAY, AUGUST 22nd 2019

08:45
Jyrki Heino, Biocity Turku
Opening words
Jukka Kola, Rector, University of Turku
Presentation of the Elias Tillandz prize for the best publication in BioCity Turku 2018

 

SESSION I Early life, education of immune system (chair: Riitta Lahesmaa)

09:15
Petter Brodin,
Karolinska Institutet, Stockholm, Sweden: Immune system development in early childhood.

10:00
Roser Vento-Tormo
, Sanger Institute, UK: Reconstructing the maternal-fetal interference during early pregnancy.

10:45
POSTER SESSION A and coffee/tea with exhibition

11:15
Kathy McCoy
, University of Calgary, Canada: Microbiome, Metabolites and Immune Responses.

12:00
Short presentations

12:30
Lunch and exhibition

 

SESSION II – Host metabolism and inflammation, metabolic disorders (Chair: Pirjo Nuutila)

13:45
Francesc Villarroya
, University of Barcelona, Spain: Cross-talk of immune cells and brown adipocytes in the control of adaptive energy metabolism.

14:30
Gökhan S. Hotamışlıgil
, Harvard University TH Chan School of Public Health, Boston, USA: Foundations of immunometabolism and implications for metabolic health and disease.

15:15
Ulf Smith
, University of Gothenburg, Sweden: Senescence impairs cell differentiation and promotes inflammation in the adipose tissue.

16:00
End of first symposium day

19:30
Symposium dinner in Turku Castle

 

FRIDAY, AUGUST 23rd 2019

 

SESSION III – Neuro-immunology, microglia and neurodegenerative diseases (Chair: Juha Rinne and Laura Airas)

09:00
David Pitt
, Yale School of Medicine, New Haven, USA: Astrocytes as mediators of inflammation in multiple sclerosis.

09:45
Anna Orr
, Weill Cornell Medicine, New York, USA: Glial Cells and Neuroimmune Signaling in Cognitive Deficits.

10:30
POSTER SESSION B and coffee/tea with exhibition

11:00
Bengt Winblad
, Karolinska Institutet, Stockholm, Sweden: Immunological treatment in Alzheimer’s disease.

11:45
Lunch and exhibition

 

SESSION IV – Onco-immunology to cure cancer (chair: Sirpa Jalkanen)

13:00
Arlene Sharpe
, Harvard Medical School, Boston, USA: The biology behind PD-1 checkpoint blockade.

13:45
Angelica Loskog
, Uppsala University, Sweden: CD40L/41BBL immunotherapy in pancreatic cancer – phase I/II interim report.

14:30
Tyler Curiel
, UTHSCSA, Medicine, San Antonio, USA: Age effects on cancer immunotherapy.

15:15
Alexander Eggermont
, Gustave Roussy CCC, France: The Immunotherapy Revolution: from melanoma to (almost) all tumors.

16:00
Jyrki Heino
, University of Turku, Closing remarks